PHD BIOSCIENCES

PHD BIOSCIENCES

PHD Biosciences (formerly Nanometics LLC) is a New York City based biosciences company developing small molecule therapeutics for diseases with high unmet medical need. The PHD Biosciences research pipeline is complimented by revenue from non-dilutive grants that total more than $7 million since 2010. These include: several Small Business Innovation Research (SBIR) awards from the National Cancer Institute (NCI), and National Heart Lung and Blood Institute (NHLBI), a Small Business Technology Transfer (STTR) award from the NCI, funding from the Avon Foundation for Women, and three Center for Advanced Technology awards from New York State.

SMALL MOLECULE THERAPEUTICS

Our small molecule program is developing targeted enzyme inhibitors for oncology and sickle cell disease. These picomolar inhibitors demonstrate impressive efficacy and extremely low toxicity. Please see the INNOVATIONS page for information.

OTC AND SKIN CARE PRODUCTS

The over the counter (OTC) drug and skin care programs have been divested into PHD Skin Care. Please visit www.phdskincare.com, or email info@phdbiosciences.com for information.

INNOVATIONS

recent news


FEB 2015
PHD Biosciences will collaborate with Grant Industries Inc. and PHD Skin Care on the development of topical formulations for skin cancer prevention. The collaboration will utilize the PHD Biosciences long-wear sunscreen technology, extensive expertise of Grant Industries, and the PHD Skin Care Never Miss A SpotTM applicator to provide for the most efficient sunscreen products available.

  read more

DERMATOLOGY

Please visit www.phdskincare.com for additional information about our OTC and Skin Care products.

INFO@PHDBIOSCIENCES | 646.801.3872 | 14 EAST 4TH STREET, SUITE 811, NEW YORK, NY 10012

©2015 PHDBIOSCIENCES